TRIDENT LIFELINE
Back to Balance Sheet
|
TRIDENT LIFELINE Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|
| Total Non-Current Liabilities | ₹30 Cr | ₹13 Cr | ₹3.41 Cr | ₹0.45 Cr |
What is the latest Total Non-Current Liabilities ratio of TRIDENT LIFELINE ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹30 Cr |
| Mar2024 | ₹13 Cr |
| Mar2023 | ₹3.41 Cr |
| Mar2022 | ₹0.45 Cr |
How is Total Non-Current Liabilities of TRIDENT LIFELINE Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹30 Cr | 138.92 | |
| Mar2024 | ₹13 Cr | 273.03 | |
| Mar2023 | ₹3.41 Cr | 652.98 | |
| Mar2022 | ₹0.45 Cr | - | |
Compare Total Non-Current Liabilities of peers of TRIDENT LIFELINE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TRIDENT LIFELINE | ₹318.9 Cr | -2.9% | -7.1% | -7.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹419,728.0 Cr | -0.8% | 7.4% | 8.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹167,236.0 Cr | -1.5% | 5.7% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹146,951.0 Cr | -1.8% | 8.8% | 44.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹107,765.0 Cr | -1.2% | 9.2% | 14.9% | Stock Analytics | |
| CIPLA | ₹106,033.0 Cr | -2.5% | 0.1% | -7.6% | Stock Analytics | |
TRIDENT LIFELINE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TRIDENT LIFELINE | -2.9% |
-7.1% |
-7.8% |
| SENSEX | -3.8% |
-2% |
6.3% |
You may also like the below Video Courses